NEW YORK (GenomeWeb) – Investment bank Cowen today initiated coverage of NanoString Technologies.

In a research note, analyst Doug Schenkel gave shares of NanoString an Outperform rating with a price target of $20 per share.

"We view the risk/reward as compelling given the track record, predictable growth model, and upside sources," he said.  Over the next two to five years, NanoString can generate sales growth "exceeding most other companies in the group, and the growth outlook is relatively predictable given the company's razor/blade model," Schenkel said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.